198 related articles for article (PubMed ID: 20142849)
1. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Izuta H; Matsunaga N; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2010 Jan; 16():130-6. PubMed ID: 20142849
[TBL] [Abstract][Full Text] [Related]
2. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
3. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.
Izuta H; Chikaraishi Y; Adachi T; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2009 Dec; 15():2663-72. PubMed ID: 20011081
[TBL] [Abstract][Full Text] [Related]
4. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
5. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
[TBL] [Abstract][Full Text] [Related]
6. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
7. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
8. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
10. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
11. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
12. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
13. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
14. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
16. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
17. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
18. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy.
Suzuki Y; Yao T; Okumura K; Seko Y; Kitano S
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1519-1525. PubMed ID: 31062144
[TBL] [Abstract][Full Text] [Related]
19. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.
Yokoi M; Yamagishi SI; Takeuchi M; Ohgami K; Okamoto T; Saito W; Muramatsu M; Imaizumi T; Ohno S
Br J Ophthalmol; 2005 Jun; 89(6):673-5. PubMed ID: 15923499
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
Lu Q; Lu L; Chen W; Lu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
